72 related articles for article (PubMed ID: 12434121)
1. p53 and Ki-67 expression in epithelial gastric dysplasia and in gastric cancer.
Testino G; Gada D; De Iaco F; Cornaggia M
Panminerva Med; 2002 Dec; 44(4):369-71. PubMed ID: 12434121
[TBL] [Abstract][Full Text] [Related]
2. Low- and high-grade non-invasive gastric neoplasia (formerly dysplasia): cytological differentiation (gastro-entero-pancreatic antigens) in association with p53 pattern expression.
Testino G; Cornaggia M; Ferrando V
Hepatogastroenterology; 2007; 54(73):1-3. PubMed ID: 17419219
[TBL] [Abstract][Full Text] [Related]
3. [High and low grade gastric epithelial dysplasia: clinical management, endoscopic assessment of p53].
Testino G; Cornaggia M; De Iaco F; Gada D
Ann Ital Med Int; 2003; 18(4):231-7. PubMed ID: 14971711
[TBL] [Abstract][Full Text] [Related]
4. Is it possible with an immunophenotypic study to foresee the oncologic risk of epithelial gastric dysplasia?
Testino G; Cornaggia M; De Iaco F; Gada D
Hepatogastroenterology; 2002; 49(45):601-3. PubMed ID: 12063949
[TBL] [Abstract][Full Text] [Related]
5. Analysis of mucin, p53 protein and Ki-67 expressions in gastric differentiated-type intramucosal neoplastic lesions obtained from endoscopic mucosal resection samples: a proposal for a new classification of intramucosal neoplastic lesions based on nuclear atypia.
Sugai T; Inomata M; Uesugi N; Jiao YF; Endoh M; Orii S; Nakamura S
Pathol Int; 2004 Jun; 54(6):425-35. PubMed ID: 15144402
[TBL] [Abstract][Full Text] [Related]
6. [Ki-67 and p53 expression in gastric dysplasias and cancer].
Lazarev AF; Klimachev VV; Avdalian AM; Bobrov IP; Zor'kin VT
Arkh Patol; 2006; 68(3):6-10. PubMed ID: 16830615
[TBL] [Abstract][Full Text] [Related]
7. Gastric dysplasia-like epithelial atypia associated with chemoradiotherapy for esophageal cancer: a clinicopathologic and immunohistochemical study of 15 cases.
Brien TP; Farraye FA; Odze RD
Mod Pathol; 2001 May; 14(5):389-96. PubMed ID: 11353047
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 protein in normal, dysplastic, and malignant gastric mucosa: an immunohistochemical study.
Joypaul BV; Newman EL; Hopwood D; Grant A; Qureshi S; Lane DP; Cuschieri A
J Pathol; 1993 Jul; 170(3):279-83. PubMed ID: 8133401
[TBL] [Abstract][Full Text] [Related]
9. [The relation between Helicobacter pylori infection and p53 mutation, MG-7 antigen and AgNORs expression in the development of gastric mucosa lesions].
Yang GB; Hu FL; Lü YY
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1331-5. PubMed ID: 12930689
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions.
Anagnostopoulos GK; Stefanou D; Arkoumani E; Karagiannis J; Paraskeva K; Chalkley L; Habilomati E; Tsianos E; Agnantis NJ
J Gastroenterol Hepatol; 2008 Apr; 23(4):626-31. PubMed ID: 18397488
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic variation and outcome for high-grade gastric epithelial dysplasia.
Sarela AI; Scott N; Verbeke CS; Wyatt JI; Dexter SP; Sue-Ling HM; Guillou PJ
Arch Surg; 2005 Jul; 140(7):644-9. PubMed ID: 16027328
[TBL] [Abstract][Full Text] [Related]
12. [Expression of p53 and Ki-67 genes in epithelial dysplasia from old oral mucosa and clinical significance].
Zhao J; Guo B; Ma SC; Zhou XD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):689-91. PubMed ID: 16235539
[TBL] [Abstract][Full Text] [Related]
13. Epithelial cell kinetics of the gastric mucosa during Helicobacter pylori infection.
Holck S; Holm IL; Holck PP; Pedersen M; Nørgaard A; Norn S; Permin H; Andersen LP
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):206-12. PubMed ID: 17521356
[TBL] [Abstract][Full Text] [Related]
14. Gastric precancerous changes: carcinogenesis, clinical behaviour immunophenotype study and surveillance.
Testino G
Panminerva Med; 2006 Jun; 48(2):109-18. PubMed ID: 16953148
[TBL] [Abstract][Full Text] [Related]
15. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
16. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
[TBL] [Abstract][Full Text] [Related]
17. Low presence of p53 abnormalities in H pylori-infected gastric mucosa and in gastric adenocarcinoma.
Berloco P; Russo F; Cariola F; Gentile M; Giorgio P; Caruso ML; Valentini AM; Di Matteo G; Di Leo A
J Gastroenterol; 2003; 38(1):28-36. PubMed ID: 12560919
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
19. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins.
Pan W; Ishii H; Ebihara Y; Gobe G
J Surg Oncol; 2003 Feb; 82(2):104-10. PubMed ID: 12561066
[TBL] [Abstract][Full Text] [Related]
20. Influence of H. pylori infection and eradication on p53, c-erbB-2 and Ki-67 in gastric mucosa.
Brajsa K; Ferencic Z; Katicic M; Radosevic S; Presecki V; Spaventi R; Dominis M
Hepatogastroenterology; 2006; 53(72):968-72. PubMed ID: 17153465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
